Skip to main content
iwCLL 2025 Main banner
Final Program


Save The Date

    (1717) MVA-based GEO-CM04S1 vaccine results in improved cellular immune response in patients with chronic lymphocytic leukemia (CLL) compared with mRNA-based vaccine: initial results of a Phase II randomized study

    Sunday, September 14, 2025
    15:40 - 15:45 CEST
    Location: ICE, Auditorium Hall (S1), Entrances On Level 0 & 1
    Oral P

      Primary Author / Presenter(s)

    • Alexey V. Danilov, MD, PhD

      Professor
      Department of Hematology and Transplantation, City of Hope National Medical Center
      Duarte, California, United States